Marc Maltas

Corporate Officer/Principal presso Octapharma AG

Health Technology

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Wolfgang Marguerre	M	83	Octapharma AG Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland.	-
Nicholas Jacobson	M	-	Octapharma AG Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland.	-
Frederic Marguerre	M	-	Octapharma AG Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland.	-
Daniel Wyder	M	-	Octapharma AG Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland.	-
Marlis Kueng	F	-	Octapharma AG Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland.	-
Roger MÃ¤chler	M	-	Octapharma AG Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland.	-
Matt Riordan	M	-	Octapharma AG Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland.	-